Abstract：
Robotic-assisted colon surgery may contain advantages over the laparoscopic approach, but clear evidence is sparse. This study aimed to analyze postoperative inflammation status, short-term outcome and cost-effectiveness of robotic-assisted versus laparoscopic left hemicolectomy. All consecutive patients who received minimal-invasive left hemicolectomy at the Department of Surgery I at the University Hospital of Wuerzburg in 2021 were prospectively included. Importantly, no patient selection for either procedure was carried out. The robotic-assisted versus laparoscopic approaches were compared head to head for postoperative short-term outcomes as well as cost-effectiveness. A total of 61 patients were included, with 26 patients having received a robotic-assisted approach. Baseline characteristics did not differ among the groups. Patients receiving a robotic-assisted approach had a significantly decreased length of hospital stay as well as lower rates of complications in comparison to patients who received laparoscopic surgery (n = 35). In addition, C-reactive protein as a marker of systemic stress response was significantly reduced postoperatively in patients who were operated on in a robotic-assisted manner. Consequently, robotic-assisted surgery could be performed in a cost-effective manner. Thus, robotic-assisted left hemicolectomy represents a safe and cost-effective procedure and might improve patient outcomes in comparison to laparoscopic surgery.
摘要：
机器人辅助结肠手术可能比腹腔镜手术更具优势。但明确的证据很少.本研究旨在分析术后炎症状态,机器人辅助与腹腔镜左半结肠切除术的短期结果和成本效益。所有2021年在乌尔兹堡大学医院外科I部接受微创左半结肠切除术的连续患者均被前瞻性纳入。重要的是,未对任何一种手术进行患者选择.比较了机器人辅助与腹腔镜方法的术后短期结果和成本效益。共纳入61例患者，26名患者接受了机器人辅助方法。各组之间的基线特征没有差异。与接受腹腔镜手术的患者相比，接受机器人辅助方法的患者住院时间显着减少，并发症发生率降低（n=35）。此外,在以机器人辅助方式进行手术的患者中，C反应蛋白作为全身应激反应的标志物在术后显着降低。因此,机器人辅助手术可以以经济有效的方式进行。因此，机器人辅助左半结肠切除术是一种安全且具有成本效益的手术,与腹腔镜手术相比,它可以改善患者的预后.
